Johnson & Johnson
(XTER:JNJ)
€
146.52
-1.08 (-0.73%)
Market Cap: 352.08 Bil
Enterprise Value: 366.43 Bil
PE Ratio: 10.19
PB Ratio: 5.49
GF Score: 75/100 Johnson & Johnson at Wells Fargo Healthcare Conference Transcript
Sep 07, 2022 / 03:00PM GMT
Release Date Price:
€164.82
(-0.89%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with Johnson & Johnson. With us, we have Ashley McEvoy, who is the Executive Vice President, Worldwide Chairman of Medical Devices. In terms of format, it's going to be a fireside chat. If anyone has a question in the audience, just raise your hand, and we'll call on you. So Ashley, thanks so much for being here.
Ashley A. McEvoy
Johnson & Johnson - Executive VP & Worldwide Chairman of MedTech
Pleasure to be here, Larry.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
So Ashley, we've been starting all of these fireside chats with questions on the macro environment, no surprise. So I'd love to hear from you kind of on what you're seeing. Given how big
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot